Advertisement
Advertisement
BLFS
BioLife Solutions Inc.
22.45
USDSponsored
+0.43
+1.94%
Feb 06, 15:59 UTC -5
Closed
After-Market
22.44
-0.01
-0.04%
BLFS Earnings Reports
Positive Surprise Ratio
BLFS beat 22 of 40 last estimates.
55%
Next Report
Date of Next Report
Mar 02, 2026
Estimate for Q4 25 (Revenue/ EPS)
$24.56M
/-$0.02
Implied change from Q3 25 (Revenue/ EPS)
-12.48%
/-300.00%
Implied change from Q4 24 (Revenue/ EPS)
+8.15%
/-107.69%
BioLife Solutions Inc. earnings per share and revenue
On Nov 06, 2025, BLFS reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.01 USD, resulting in a 184.03% surprise. Revenue reached 28.07 million, compared to an expected 26.21 million, with a 7.10% difference. The market reacted with a -4.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 24.56 million USD, implying an decrease of -300.00% EPS, and decrease of -12.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
FAQ
What were BioLife Solutions Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioLife Solutions Inc. reported EPS of $0.01, beating estimates by 184.03%, and revenue of $28.07M, 7.1% above expectations.
How did the market react to BioLife Solutions Inc.'s Q3 2025 earnings?
The stock price moved down -4.03%, changed from $27.02 before the earnings release to $25.93 the day after.
When is BioLife Solutions Inc. expected to report next?
The next earning report is scheduled for Mar 02, 2026.
What are the forecasts for BioLife Solutions Inc.'s next earnings report?
Based on 12
analysts, BioLife Solutions Inc. is expected to report EPS of -$0.02 and revenue of $24.56M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement